Tarsus Pharmaceuticals, Inc. TARS Business Segments — Total Costs & Expenses

Similar metrics at other companies

UEReportable Segment — Total Costs & Expenses

$48.46M+11.7%

GRNDReportable Segment — Total Costs & Expenses

$87.21M+27.2%

TWSTReportable Segment — Total Costs & Expenses

$156.58M+16.5%

CONReportable Segment — Total Costs & Expenses

$448.87M+12.8%

GRALReportable Segment — Total Costs & Expenses

$176.55M-4.8%

ACHRReportable Segment — Total Costs & Expenses

$256.2M+77.9%

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s business segments — total costs & expenses?

Tarsus Pharmaceuticals, Inc. (TARS) reported business segments — total costs & expenses of $168.18M in Q1 2026.

How has Tarsus Pharmaceuticals, Inc.'s business segments — total costs & expenses changed year-over-year?

Tarsus Pharmaceuticals, Inc.'s business segments — total costs & expenses increased by 60.8% year-over-year, from $104.62M to $168.18M.

What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s business segments — total costs & expenses?

Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s business segments — total costs & expenses has grown at a 80.7% compound annual growth rate (CAGR), from $88.53M to $522.33M.

What does business segments — total costs & expenses mean?

The aggregate of all operating costs, including research, development, marketing, and administrative overheads incurred by the business segment. This metric provides a comprehensive view of the total resource consumption required to maintain operations.